M&T Bank
SAGE

M&T Bank’s Sage Therapeutics SAGE Stock Holding History

M&T Bank’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-13
Closed -$107K – 1656
2019
Q2 		$107K Hold
13
– – ﹤0.01% 1491
2019
Q1 		$80K Buy
13
+8
+160% +$1.16K ﹤0.01% 1500
2018
Q4 		$7K Hold
5
– – ﹤0.01% 1404
2018
Q3 		$23K Hold
5
– – ﹤0.01% 1497
2018
Q2 		$32K Buy
+5
New +$785 ﹤0.01% 1496

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

M&T Bank's SAGE Position: Q4 2019 in Review

M&T Bank sold out of Sage Therapeutics (SAGE) in Q4 2019, closing a stake of 2,096 shares — an estimated $294K sold.

M&T Bank first reported a position in SAGE in Q4 2015 and held it in 7 quarters. The position peaked at $620K in Q2 2019. 266 funds tracked by Wall St. Rank hold SAGE as of Q4 2019.

  • M&T Bank reported no remaining Sage Therapeutics position as of Q4 2019 after selling out during the quarter.
  • M&T Bank sold 2,096 Sage Therapeutics shares in Q4 2019, an estimated $294K.
  • M&T Bank first reported a position in Sage Therapeutics in Q4 2015 and held it in 7 quarters.
  • M&T Bank's Sage Therapeutics position peaked at $620K in Q2 2019.
  • 266 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2019.

Based on M&T Bank's 13F filing for Q4 2019, filed 7 Feb 2020.